We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

56 hedge funds and large institutions have $541M invested in Akcea Therapeutics Inc in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $3.19M | Put options by funds: $2.42M

28% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 18

3% more capital invested

Capital invested by funds: $526M → $541M (+$14.9M)

2% less funds holding

Funds holding: 57 → 56 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
56
Holders Change
-1
Holders Change %
-1.75%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
23
Reduced
18
Closed
9
Calls
$3.19M
Puts
$2.42M
Net Calls
+$774K
Net Calls Change
+$537K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$58.4M
2
BG
Bellevue Group
Switzerland
+$7.89M
3
AA
ALPS Advisors
Colorado
+$2.94M
4
BlackRock
BlackRock
New York
+$2.89M
5
BB
BB Biotech
Switzerland
+$2.26M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$18.6M
2
EAM
Eventide Asset Management
Massachusetts
-$4.48M
3
PA
Perceptive Advisors
New York
-$2.49M
4
Jane Street
Jane Street
New York
-$524K
5
TCIM
TIAA CREF Investment Management
New York
-$386K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$295M +$58.4M +2,447,367 +24%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$61.8M -$18.6M -779,544 -23%
BB
3
BB Biotech
Switzerland
$58.9M +$2.26M +94,500 +4%
BlackRock
4
BlackRock
New York
$45.1M +$2.89M +121,184 +7%
Vanguard Group
5
Vanguard Group
Pennsylvania
$27.5M +$860K +36,039 +3%
BG
6
Bellevue Group
Switzerland
$8.99M +$7.89M +330,502 +677%
State Street
7
State Street
Massachusetts
$6.17M -$7.16K -300 -0.1%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$4.82M -$95.7K -4,008 -2%
AGA
9
Altrinsic Global Advisors
Connecticut
$4.69M +$239K +10,000 +5%
Northern Trust
10
Northern Trust
Illinois
$4.36M +$314K +13,147 +8%
Morgan Stanley
11
Morgan Stanley
New York
$3.02M +$2.18M +91,219 +253%
AA
12
ALPS Advisors
Colorado
$2.92M +$2.94M +123,368 New
Charles Schwab
13
Charles Schwab
California
$1.69M -$121K -5,082 -7%
Goldman Sachs
14
Goldman Sachs
New York
$1.52M +$485K +20,326 +46%
Millennium Management
15
Millennium Management
New York
$1.52M +$1.24M +51,894 +429%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$1.34M -$201K -8,426 -13%
Deutsche Bank
17
Deutsche Bank
Germany
$1.18M +$437K +18,317 +58%
ProShare Advisors
18
ProShare Advisors
Maryland
$893K +$118K +4,926 +15%
AllianceBernstein
19
AllianceBernstein
Tennessee
$863K +$258K +10,800 +42%
Wells Fargo
20
Wells Fargo
California
$807K +$243K +10,187 +43%
VEA
21
Virtus ETF Advisers
New York
$790K -$144K -6,036 -15%
TCIM
22
TIAA CREF Investment Management
New York
$774K -$386K -16,155 -33%
Swiss National Bank
23
Swiss National Bank
Switzerland
$671K – – –
TA
24
Teachers Advisors
New York
$623K -$38.1K -1,598 -6%
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$463K -$87.4K -3,663 -16%
1
2 3

AKCA Hedge Fund Activity: Q2 2018 in Review

56 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q2 2018, worth a combined $541M — up 2.8% from $526M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of AKCA and 8 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 23 added.

The largest buyer was Fidelity Investments, adding an estimated $58.4M. The largest seller was Wellington Management Group, cutting an estimated $18.6M.

  • 56 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q2 2018, down from 57 in Q1 2018.
  • Funds reported $541M of Akcea Therapeutics Inc stock for Q2 2018, up 2.8% quarter-over-quarter.
  • 8 funds opened new Akcea Therapeutics Inc positions in Q2 2018 and 9 closed out, a net change of -1 holder.
  • The largest Akcea Therapeutics Inc buyer in Q2 2018 was Fidelity Investments, an estimated $58.4M added.
  • The largest Akcea Therapeutics Inc seller in Q2 2018 was Wellington Management Group, an estimated $18.6M sold.

Based on aggregated 13F filings for Q2 2018.